InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Patel Sandip I. Director active across 5 companies, notably Akari Therapeutics Plc. In total, 5 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €3k. History available since 9 March 2023. The latest transaction was filed on 6 March 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Patel Sandip I is a declarant associated, in the filings reviewed, with Akari Therapeutics Plc, Peak Bio, Inc., AtlasClear Holdings, Inc., Quantum FinTech Acquisition Corp and Monterey Innovation Acquisition Corp, where the listed role is Director. The 5 filings total 3242 EUR of sales in the sampled recent filings, covering the period from 2023-03-13 to 2025-04-29, and the most common transaction nature is Attribution.